Meeting at the crossroads of pain and addiction: An ethical analysis of pain management with palliative care for individuals with substance use disorders

Adele Flaherty, MA, PhD Candidate; Fahmida Hossain, MS, HEC-C, PhD Candidate; Alexa Vercelli, MA

doi:10.5055/jom.2021.0631

Authors

Adele Flaherty, MA, PhD Candidate https://orcid.org/0000-0003-3850-0660
Fahmida Hossain, MS, HEC-C, PhD Candidate
Alexa Vercelli, MA

DOI:

https://doi.org/10.5055/jom.2021.0631

Keywords:

opioid use disorder (OUD), palliative care, addiction, dignity-enhancing care, pain, stigma

Abstract

A growing number of individuals live with an opioid use disorder (OUD). While many go on to recover from such disorders, certainly, there will be individuals in palliative care (PC) at some point who still suffer with OUD. One of the major barriers to PC for individuals recovering and currently suffering from an OUD is the stigma related to having an OUD. Therefore, in the context of PC, it is important to understand the relationship that exists between PC, OUDs, and how stereotypes related to substance use disorders affect patient engagement in PC. For this paper, the focus will be on how stereotypes affect pain management in PC for persons with an OUD. A review of current literature regarding OUDs and pain management indicates a need for care specific to the needs of those in PC who formerly and/or currently suffer from an OUD in order to avoid relapse or worsening of their affliction while still managing their pain. The striking lack of knowledge and resources regarding OUDs and their treatment indicates a need to strengthen/increase resources for physicians to educate on treating OUDs as well as alternatives for pain management. This article presents dignity-enhancing care as a gateway to fairly treat individuals with an OUD and to get rid of the stigma associated with OUD patients.

Author Biographies

Adele Flaherty, MA, PhD Candidate

Center for Healthcare Ethics, Duquesne University McAnulty College and Graduate School of Liberal Arts, Pittsburgh, Pennsylvania

Fahmida Hossain, MS, HEC-C, PhD Candidate

Center for Healthcare Ethics, Duquesne University McAnulty College and Graduate School of Liberal Arts, Pittsburgh, Pennsylvania

Alexa Vercelli, MA

PhD and DO Student, Duquesne University McAnulty College and Graduate School of Liberal Arts, Pittsburgh, Pennsylvania; Liberty University College of Medicine, Campbell County, Virginia

References

Palliative care: Key facts. 2018. Available at https://www.who.int/news-room/factsheets/detail/palliative-care. Accessed March 30, 2019.

Palliative care facts and stats. 2015. Available at https://media.capc.org/filer_public/68/bc/68bc93c7-14ad-4741-9830-8691729618d0/capc_press-kit.pdf. Accessed April 3, 2019.

SAMHSA 2018: National survey on drug use and health. 2019. https://www.samhsa.gov/data/report/2018-nsduh-annualnational-report. Accessed April 3, 2019.

Groninger H, Knapik M: Twelve-step programs and spiritual support at the end of life. Am J Hosp Palliat Med. 2019; 36(9): 807-808.

Fitzpatrick M: “Stigma.” Br J Gen Pract. 2008; 58(549): 294. DOI:10.3399/bjgp08X280092.

Chaudoir SR, Earnshaw VA, Andel S: “Discredited” versus “Discreditable”: Understanding how shared and unique stigma mechanisms affect psychological and physical health disparities. Basic Appl Soc Psychol. 2013; 35(1): 78-80. DOI:10.1080/01973533.2012.746612.

Murphy MC, Steele CM, Gross JJ: Signaling threat: How situational cues affect women in math, science, and engineering settings. Psychol Sci. 2007; 18(10): 882-885. DOI:10.1111/j.1467-9280.2007.01995.x.

Fitzpatrick M: “Stigma.” Br J Gen Pract. 2008; 58(549): 294. DOI:10.3399/bjgp08X280092.

Volkow ND, Koob GF, McLellan AT: Neurobiologic advances from the brain disease model of addiction. N Engl J Med. 2016; 374(4): 366-371. DOI:10.1056/NEJMra1511480.

Kollas C, Kollas BB: Assessing opioid stigma in oncology outpatients receiving palliative care for cancer-related pain (S714). J Pain Symp Manag. 2018; 55(2): 663-664. DOI:10.1016/j.jpainsymman.2017.12.368.

National Center for Biotechnology Information: Carfentanil CID=62156. PubChem Database. 2017. https://pubchem.ncbi.nlm.nih.gov/compound/Carfentanil. Accessed September 8, 2019.

Livingston JD, Milne T, Fang ML, et al.: The effectiveness of interventions for reducing stigma related to substance use disorders: A systematic review. Addiction. 2012; 107(1): 41-45. DOI:10.1111/j.1360-0443.2011.03601.x.

Kulesza M, Larimer ME, Rao D: Substance use related stigma: What we know and the way forward. J Addict Behav Ther Rehabil. 2013; 2(2): 782.

Olsen Y, Sharfstein JM: Confronting the stigma of opioid use disorder—and its treatment. JAMA. 2014; 311(14): 1393-1394. DOI:10.1001/jama.2014.2147.

Ebenau A, Dijkstra B, Ter Huurne C, et al.: Palliative care for patients with substance use disorder and multiple problems: A qualitative study on experiences of healthcare professionals, volunteers and experts-by-experience. BMC Palliat Care. 2020; 19(1): 8-8. DOI:10.1186/s12904-019-0502-x.

National Academies of Sciences, Engineering, and Medicine: Understanding stigma of mental and substance use disorders. In Ending Discrimination Against People with Mental and Substance Use Disorders: The Evidence for Stigma Change. Washington, DC: National Academies Press, 2016. Available at https://www.ncbi.nlm.nih.gov/books/NBK384923/. Accessed February 4, 2019.

Ebenau A, Dijkstra B, Ter Huurne C, et al.: Palliative care for patients with substance use disorder and multiple problems: A qualitative study on experiences of healthcare professionals, volunteers and experts-by-experience. BMC Palliat Care 2020; 19(1): 8-8. DOI:10.1186/s12904-019-0502-x.

Kirsh KL, Passik SD: Palliative care of the terminally ill drug addict. Cancer Invest 2006; 24(4): 425-431. DOI:10.1080/07357900600705565.

Meier D, Beresford L: Safely managing pain | People with serious illnesses | Palliative in practice. [online] Capc.org. 2018. Available at https://www.capc.org/blog/palliative-pulse-the-palliative-pulse-december-2018-balancing-pain-treatment-withrisks-of-comorbid-substance-use-disorder-for-patients-with-serious-illness/. Accessed November 13, 2019.

Dineen KK, DuBois JM: Between a rock and a hard place: Can physicians prescribe opioids to treat pain adequately while avoiding legal sanction?. Am J Law Med. 2016; 42(1): 21-28. DOI:10.1177/009885881664471.

Hossain F: Global responsibility vs. individual dreams: Addressing ethical dilemmas created by the migration of healthcare practitioners. Glob Bioeth. 2020; 31(1): 81-89. DOI:10.1080/11287462.2020.1773054.

Tuohey JF: Balancing benefit and burden. Merely avoiding harm does not carry out the intent of the Hippocratic oath. Health Prog. 1989; 70(1): 77-79.

Hossain F, Clatty A: “Self-care strategies in response to nurses’ moral injury during COVID-19 pandemic. Nurs Ethics. 2020. DOI:10.1177/0969733020961825.

Prater CD, Zylstra RG, Miller KE: Successful pain management for the recovering addicted patient. J Clin Psychiatr. 2002; 4(4): 126-128. DOI:10.4088/pcc.v04n0402.

Volkow ND, Koob GF, McLellan AT: Neurobiologic advances from the brain disease model of addiction. N Engl J Med. 2016; 374(4): 366-371. DOI:10.1056/NEJMra1511480.

Goel N, Munshi LB, Thyagarajan B: Intravenous drug abuse by patients inside the hospital: A cause for sustained bacteremia. Case Rep Infect Dis. 2016; 1738742-1738742.DOI:10.1155/2016/1738742.

Mallon WK: Is it acceptable to discharge a heroin user with an intravenous line to complete his antibiotic therapy for cellulitis at home under a nurse's supervision? No: A home central line is too hazardous. Western J Med. 2001; 174(3): 157-157. DOI:10.1136/ewjm.174.3.157.

Suzuki J, Johnson J, Montgomery M, et al.: Outpatient parenteral antimicrobial therapy among people who inject drugs: A review of the literature. Open Forum Infect Dis. 2018; 5(9): ofy194-ofy94. DOI:10.1093/ofid/ofy19.

Pettersen H, Landheim A, Skeie I, et al.: How social relationships influence substance use disorder recovery: A collaborative narrative study. Subst Abuse. 2019; 13: 1178221819833379. DOI:10.1177/1178221819833379.

Hossain F: Narrative authority: A key to culturally competent healthcare. In Gielen J (eds.): Dealing with Bioethical Issues in a Globalized World. Advancing Global Bioethics, vol. 14. Cham: Springer. DOI:10.1007/978-3-030-30432-4_12.

Yalden BJ, McCormack B: Constructions of dignity: A prerequisite for flourishing in the workplace? Int J Older People Nurs. 2010; 5(2): 145-147. DOI:10.1111/j.1748-3743.2010.00218.x.

Gabbard J, Jordan A, Mitchell J, et al.: Dying on hospice in the midst of an opioid crisis: What should we do now? Am J Hosp Palliat Med. 2019; 36(4): 274-275. DOI:10.1177/1049909118806664.

ten Have H: Vulnerability: Challenging Bioethics. Abingdon: Routledge, Taylor & Francis Group, 2016.

Gastmans C: Dignity-enhancing nursing care: A foundational ethical framework. Nurs Ethics. 2013; 20(2): 142-144. DOI:10.1177/0969733012473772.

Hossain F: Moral distress among healthcare providers and mistrust among patients during COVID-19 in Bangladesh. Dev World Bioeth. 2020. DOI: 10.1111/dewb.12291.

Brunton S: I have never liked the term “Compliance”. Clin

Diabetes. 2017; 35(2): 76-77. DOI:10.2337/cd17-0010.